Control Bionics Overview
- Status
-
Public
- Employees
-
41
- Stock Symbol
-
CBL
- Investments
-
1
- Share Price
-
$0.03
- (As of Friday Closing)
Control Bionics General Information
Description
Control Bionics Ltd is a neurotechnology company commercialising objective, non-invasive neural-signal technology in clinical environments, built to scale across multiple markets. Its neural-signal platform captures physiological signals, including the electrical activity generated by muscles, with medical-grade precision, converting them into measurable, decision-ready outcomes. Its products include NeuroNode, NeuroStrip, NeuroNode Trilogy Systems, NeuroNode Duo, EyeGaze Duo, and others. Geographically, it derives a majority of its revenue from North America, with a presence in Australia, Japan, and other markets.
Contact Information
Website
www.controlbionics.comCorporate Office
- Level 4, 11-13
- Pearson Street
- Cremorne, Victoria 3121
- Australia
Corporate Office
- Level 4, 11-13
- Pearson Street
- Cremorne, Victoria 3121
- Australia
Control Bionics Timeline
Control Bionics Stock Performance
As of 20-Nov-2026, Control Bionics’s stock price is $0.03. Its current market cap is $15.3M with 544M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.03 | $0.03 | $0.03 - $0.07 | $15.3M | 544M | 438K |
Control Bionics Financials Summary
As of 30-Sep-2026, Control Bionics has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 30-Jun-2026 | FY 2025 30-Jun-2025 | FY 2024 30-Jun-2024 |
|---|---|---|---|---|
| EV | 22,512 | 19,040 | 5,434 | 6,070 |
| Revenue | 3,292 | 3,864 | 3,360 | |
| EBITDA | (4,332) | (3,267) | (3,294) | |
| Net Income | (4,922) | (3,952) | (3,876) | |
| Total Assets | 6,226 | 5,378 | 6,034 | |
| Total Debt | 426 | 284 | 643 |
Control Bionics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Control Bionics Comparisons
Industry
Financing
Details
Control Bionics Competitors (2)
One of Control Bionics’s 2 competitors is Liberator, a Corporation company based in Sydney, Australia.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Liberator | Corporation | Sydney, Australia | ||||
| Tobii Dynavox Limited | Corporation | Warwick, United Kingdom |
Control Bionics Patents
Control Bionics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026090276-A1 | Switch control system for assistive devices | Pending | 23-Oct-2024 | ||
| WO-2025250868-A1 | Method for monitoring and collecting physiological data using a flexible patch device | Pending | 30-May-2024 | ||
| AU-2024353925-A1 | Artificial intelligence-based system and method for creating digital arts and stories | Pending | 26-Sep-2023 | ||
| EP-4785124-A1 | Artificial intelligence-based system and method for creating digital arts and stories | Pending | 26-Sep-2023 | ||
| WO-2025072442-A1 | Artificial intelligence-based system and method for creating digital arts and stories | Inactive | 26-Sep-2023 | G06F3/0482 |
Control Bionics Signals
Control Bionics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Control Bionics Investments (1)
Control Bionics’s most recent deal was a Corporate with Neuro Elite Athletics for . The deal was made on 16-Dec-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Neuro Elite Athletics | 16-Dec-2024 | Corporate | Other Services (B2C Non-Financial) |
Control Bionics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Software & Services
Industry
Rank
Percentile
Enterprise and Infrastructure Software
Subindustry
Rank
Percentile
Control Bionics FAQs
-
Where is Control Bionics headquartered?
Control Bionics is headquartered in Cremorne, Australia.
-
What is the size of Control Bionics?
Control Bionics has 41 total employees.
-
What industry is Control Bionics in?
Control Bionics’s primary industry is Therapeutic Devices.
-
Is Control Bionics a private or public company?
Control Bionics is a Public company.
-
What is Control Bionics’s stock symbol?
The ticker symbol for Control Bionics is CBL.
-
What is the current stock price of Control Bionics?
As of 20-Nov-2026 the stock price of Control Bionics is $0.03.
-
What is the current market cap of Control Bionics?
The current market capitalization of Control Bionics is $15.3M.
-
Who are Control Bionics’s competitors?
Liberator and Tobii Dynavox Limited are competitors of Control Bionics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process